...read the wave
Nano Products - Nano-Produkte - Nano Producten


Wound Management

Smith & Nephew receives US FDA clearance for ACTICOAT° Moisture Control


Smith & Nephew's US Advanced Wound Management division today announced that the US Food and Drug Administration has given clearance of its newest absorbent antimicrobial barrier dressing, ACTICOAT° Moisture Control.

The clearance and introduction of ACTICOAT° Moisture Control complements the company's existing ACTICOAT° range. These are the only wound care products to feature the patented Silcryst nanocrystalline silver technology that provides antimicrobial barrier protection.

ACTICOAT° Moisture Control was developed over the last two years, through collaboration between Smith & Nephew and NUCRYST Pharmaceuticals. Smith & Nephew launched the product at the SAWC Convention on April 22nd in San Diego, as an extension to the existing ACTICOAT° family.

The current ACTICOAT° range, which encompass a three day, seven day and absorbent product have been shown to be bactericidal against a broad range of pathogens, including MRSA and VRE, and have lead the way in both burn and chronic wound care. ACTICOAT Moisture Control, with an extended wear time up to 7 days, reduces the number of dressing changes and the resources needed to change multiple dressings, adding to the comfort and quality of life of the patient.

Antimicrobial barrier dressings are increasingly used in the advanced wound care market as a barrier to bacterial penetration, a major cause of delays and complications to wound healing. As an effective barrier to pathogenic bacteria, ACTICOAT Moisture Control may help avoid serious complications associated with nosocomial outbreaks, wound infection may be avoided and duration of hospitalization and healthcare related costs reduced proportionately.

The introduction of ACTICOAT° Moisture Control now offers the bactericidal protection synonymous with the ACTICOAT range in a highly absorbent, easy to use format. New ACTICOAT Moisture Control eliminates the threats to healing and provides powerful antimicrobial barrier protection to chronic and acute wounds.

"We are very excited to announce that we have added ACTICOAT° Moisture Control to the Smith & Nephew portfolio. This new product allows us to provide even more options for our valued customers as they treat wounds that affect their patients. We strive to help people regain their lives and the addition of ACTICOAT° Moisture Control will help us do just that", said Jim Lodigiani, US Wound Management President.

About Smith & Nephew, Inc.

Smith & Nephew is a global medical technology business, specializing in Advanced Wound Management, Endoscopy, and Orthopaedics. Smith & Nephew ranks as the global leader in arthroscopy and one of the world's leaders in advanced wound management and is one of the fastest growing orthopaedics companies in the world. Smith & Nephew is dedicated to helping improve people's lives. The company prides itself on the strength of its relationships with its surgeon and professional healthcare customers, with whom its name is synonymous with the highest standards of performance, innovation and trust. The company has more than 8,000 employees and operates in 33 countries around the world and generated sales of nearly $2.3 billion.


Rod Skaggs
Smith & Nephew, Inc.
Executive Vice President of Corporate Relations



This story has been adapted from a news release -
Diese Meldung basiert auf einer Pressemitteilung -
Deze tekst is gebaseerd op een nieuwsbericht -


who is reading
the wave ?

missed some news ?
click on archive photo


or how about joining us


or contacting us ?


about us


our mission